VanEck
IE000B9PQW54.SG
IE000B9PQW54
VanEck Genomics and Healthcare Innovators UCITS ETF
Loading chart...

Risk & Diversification Scores

Transparent evaluation of price volatility (SRI) and 4-dimensional portfolio diversification.

Volatility Risk Score
4/7 Moderate
4 / 7 SRI PRIIPs Risk Class

Typical market fluctuations. Suitable for long-term wealth accumulation (3–5+ years horizon).

Volatility (5Y)
—
5-Year Horizon
Max Drawdown (5Y)
—
Deepest Drawdown
Sharpe Ratio
—
Risk / Reward
Rec. Holding Period
3 - 5+ Years
Investment Horizon
Balanced / Moderate: Score Basis:
Diversification Score
High Concentration (> 50%)
26 / 100 Portfolio Diversification
4 Dimensions: Holdings (30%) • Sectors (25%) • Industries (25%) • Regions (20%)

High concentration risk: A few heavyweights drive the majority of fund value.

Top 10 Holdings
60%
Focused
Effective Holdings
~25
of 49 holdings
Top Sector
100.0%
Healthcare
Top Region / Country
82.8%
United States
Elevated concentration in top individual holdings, leading sectors, or key regions.

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — —
3 Years — — — —
5 Years — — — —
10 Years — — — —

Notes & Warnings

🟢 Favorable / fair valuation: Avg P/E of 28.9
🟢 Deep market liquidity & capital coverage (Tier 1)
⚠️ Fund closure risk (< 50M € AUM)
🟡 Moderate analyst coverage (16.4 analysts)
🔴 Extreme top 10 holdings concentration: 60% of fund in top 10 positions.
🔴 Severe sector concentration risk: 100% in "Healthcare".
⚠️ Industry concentration: 46% in "Biotechnology".
🔴 36% of ETF holdings are unprofitable companies (severe cash-burn and fundamental financial risk).
⚠️ Elevated Regulatory & Policy Risk: 100% in heavily regulated industries (defense, regulated utilities, healthcare policy).
🟢 Strong Defensive Buffer: 54% in crisis-resilient, non-cyclical sectors (consumer staples, healthcare, utilities).
ende